Immuneering (IMRX) Depreciation and Depletion (2020 - 2024)
Immuneering's Depreciation and Depletion was $86,116 in Q4 2024, down 4.1% from $89,754 a year earlier and down 3.2% from the prior quarter.
Powered by 
Analysis
Immuneering (IMRX) Depreciation and Depletion (2020 - 2024) Analysis & Trends
For FY2024, Depreciation and Depletion at Immuneering came in at $355,807, up 10.2% from FY2023.
- Depreciation and Depletion has now increased for four consecutive years, with a four-year compound annual growth rate of 95.6% (FY2020 to FY2024).
- In earlier years, Depreciation and Depletion was $322,816 in FY2023 (+30.6%), $247,199 in FY2022 (+443.7%), $45,467 in FY2021 (+86.9%) and $24,328 in FY2020.
- The Q4 2024 figure marks the lowest quarterly Depreciation and Depletion since Q3 2023.
- Compared with a year earlier, Depreciation and Depletion was higher in seven of the last eight quarters, with growth averaging 22.3%.
- The best year-over-year quarter for Depreciation and Depletion over five years was Q3 2022 (growth of 468.3%); the worst was Q4 2024 (a decline of 4.1%).
- Per Business Quant data, IMRX's Depreciation and Depletion in the three quarters before Q4 2024 was $88,949 (Q3 2024), $90,533 (Q2 2024) and $90,209 (Q1 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | - |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 194.00 Mn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 599.00 Mn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | - |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 98.00 Mn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | - |
| 10 | Immuneering | 260.73 Mn | 260.73 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 86,116.00 |
| Sep 30, 2024 | 88,949.00 |
| Jun 30, 2024 | 90,533.00 |
| Mar 31, 2024 | 90,209.00 |
| Dec 31, 2023 | 89,754.00 |
| Sep 30, 2023 | 78,294.00 |
| Jun 30, 2023 | 78,241.00 |
| Mar 31, 2023 | 76,527.00 |
| Dec 31, 2022 | 76,862.00 |
| Sep 30, 2022 | 68,075.00 |
| Jun 30, 2022 | 54,560.00 |
| Mar 31, 2022 | 47,704.00 |
| Dec 31, 2021 | 14,815.00 |
| Sep 30, 2021 | 11,978.00 |
| Jun 30, 2021 | 9,807.00 |
| Mar 31, 2021 | 8,867.00 |
| Dec 31, 2020 | 7,449.00 |
| Sep 30, 2020 | 5,656.00 |
| Jun 30, 2020 | 5,916.00 |
API Access
Immuneering Depreciation and Depletion API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=IMRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-depletion", "ticker": "IMRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=IMRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();